Navigation Links
LabX.com’s December Holiday Listing Event has Returned!
Date:12/3/2012

Midland, ON (PRWEB) December 03, 2012

Starting Saturday, December 1st and running through till December 31st 2012, all seller fees will be discounted by 75% off regular listing fees to run ads on LabX.com in the lab glassware, lab supplies, and special selected categories (listed below). This is an excellent opportunity as this discount will be applied directly to the following ad types: Lab Drawer, Single Item for Sale and All Auctions once the listing has been entered.

As the holiday season, and New Year fast approach, be sure to get the surplus Lab Glassware and Supplies off your shelves and onto the market. Selling your unused or surplus stock in these categories has never been easier.

Qualified Categories included in this offer:

LAB SUPPLIES
Apparel, Gloves, Lab Coats
Chemicals
Cuvettes
Filtration Supplies
Gases - Specialty/Calibration
Lamps
Plasticware
Porcelain
Supplies and Labware
Valves/Fittings

GLASSWARE
Beakers
Bottles
Condensers / Distillation
Desiccators
Flasks
Funnels
Glassware – Other
Quartz Glass
Test Tubes
Vials

SPECIAL SELECTED
Centrifuge - Rotors/Parts
Heating Mantles
Hot Plates
Medical Parts
Medical Supplies
Mixers
Pipette Tips
Shakers
Stirrers
Ultrasound Transducers

Simply run an ad to automatically qualify for the discount. This event ends December 31, 2012.

Click Here to run an ad and take advantage of this listing Special! Remember, unlike other sites, LabX never charges commission or final value fees–all you pay is the up-front listing fee. Have you never run an ad on LabX before and need some help? Contact us toll-free at (888) 781-0
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Ampio Pharmaceuticals, Inc. (AMPE) announces appointment of Josh Disbrow as Chief Operating Officer effective December 15, 2012
2. Luminex Corporation To Host Investor Event December 11, 2012
3. GDS International Confirms the Attendance of Top Executives to its Eleventh North American Healthcare Summit in December
4. As Released on 30 December, 2011: Novogen Modifies ADR Program and Makes Further Investment Into Marshall Edwards
5. West Palm Beach, FL to Host 8th Annual World Stem Cell Summit December 3-5, 2012
6. Unigene to Present at the Oppenheimer 22nd Annual Healthcare Conference on December 13, 2011
7. Why Medicare Carrier Proposes Major Changes in the Handling of Code Stacked Molecular Test Claims is Topic of December 20 Audio Conference
8. Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
9. ViroPharma to Participate in Two December Healthcare Investor Conferences
10. Senesco Technologies, Inc. to Webcast, Live, at RetailInvestorConferences.com on December 1st
11. Cord Blood America Announces DTCC Removes "Chill" Imposed in December 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... -- Research and Markets  has announced the addition ... Industry Analysis, Size, Share, Growth, Trends and Forecast to ... http://photos.prnewswire.com/prnh/20130307/600769 Transfection is a ... RNA) into cells. This technology helps the cells to ... metabolism by affecting the nuclear genes. The transfection technology ...
(Date:7/11/2014)... , July 11, 2014 /CNW/ - Sunovion Pharmaceuticals Canada ... TM (eslicarbazepine acetate) for use as a once-daily ... patients with epilepsy who are not satisfactorily controlled with ... use in patients under 18 years of age. ... neurological disorders and according to Epilepsy Canada, it affects ...
(Date:7/10/2014)... 10, 2014 Women in the ... to an additional family planning option. Sayana® Press ... at all levels of the health system and ... a widely used contraceptive—Pfizer’s Depo-Provera® (depot medroxyprogesterone acetate)—with ... is the first of four African countries expected ...
(Date:7/10/2014)... 2014 Understanding the need for better ... and the gap that currently exists in this area, ... industry-leading portfolio of validated ion channel and GPCR cell ... lines, as ion channels control many critical physiological functions ... creates the potential to treat a variety of human ...
Breaking Biology Technology:International Transfection Technology Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019 2Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 2Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 3Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 4Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 2Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 3Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 4Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 5Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 6Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 2Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 3
... Fla., Dec. 6, 2010 Investigators report no evidence of ... in a gene therapy trial using a vector under development ... (University College London) to correct the inherited bleeding disorder. ... test, with low and intermediate doses of the vector expected ...
... 6, 2010 See video from Novartis at: ... Novartis announced 24-month data showing that Tasigna® (nilotinib) ... of adult patients with newly diagnosed Philadelphia chromosome-positive ... These new data, from the first Phase III ...
... Cell Therapeutics, Inc. ("the Company") (Nasdaq and MTA: ... follow up results from the Company,s pivotal phase III ... Company,s recent Marketing Authorization Application (the "MAA") currently under ... The end-of-study results showed continued improvement in the trial,s ...
Cached Biology Technology:Early Safety Results Promising for Phase I/II Trial of Gene Therapy Treatment of Hemophilia B 2Early Safety Results Promising for Phase I/II Trial of Gene Therapy Treatment of Hemophilia B 3Early Safety Results Promising for Phase I/II Trial of Gene Therapy Treatment of Hemophilia B 4New Pixantrone Data Presented at Meetings at American Society of Hematology Conference 2New Pixantrone Data Presented at Meetings at American Society of Hematology Conference 3New Pixantrone Data Presented at Meetings at American Society of Hematology Conference 4New Pixantrone Data Presented at Meetings at American Society of Hematology Conference 5New Pixantrone Data Presented at Meetings at American Society of Hematology Conference 6
(Date:7/10/2014)... -- Smart technology emphasis grows in biometrics sector ... NXT-ID, Inc. (OTCBB: NXTD), eBay Inc. (NASDAQ: EBAY ... (NASDAQ: AAPL ), Visa Inc. (NYSE: ... (OTCQB: NXTD) a biometric authentication company focused on the growing ... of 30 second spots on CNBC for its next generation ...
(Date:7/10/2014)... 2, 2014 It is a great honor ... appointment of the world-renowned Thoracic and Cardiovascular surgeon, Mark ... Dr. Ginsburg, with over 34 years of experience, ... and Good Samaritan Regional Medical Center. Dr. Ginsburg has ... 1980,s and is considered an expert in the implantation ...
(Date:7/10/2014)... According to the new market ... Area), Material (Optical Prism, Pizeoelectric, Capacitive, and Adhesives), Application ... & Finance), and Geography - Global Trends & Forecasts ... Fingerprint Sensors Market is projected to cross $14.35 Billion ... from 2014 to 2020. Browse more than ...
Breaking Biology News(10 mins):Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 2Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 3Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 4Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 5Avery Biomedical Devices, Inc. announces the appointment of Mark E Ginsburg, M.D. to its Board of Directors 2Fingerprint Sensors Market worth $14.35 Billion by 2020 2Fingerprint Sensors Market worth $14.35 Billion by 2020 3
... with atrial fibrillation are often treated with anticoagulants to ... dose and patients have to have their blood tested ... of Gothenburg and Chalmers University of Technology have now ... risk assessments. Atrial fibrillation, or irregular heartbeat, ...
... day of competition in London, a team of four ... emerged as the winners of this year,s Biotechnology Young ... Biotechnology Young Entrepreneurs Scheme (YES) competition are Ben Owens, ... University of Oxford. The team pitched their ...
... industry is booming more and more solar modules ... plants are increasingly feeding power into the grid. Multi-junction ... can achieve efficiencies of up to 43 percent - ... crystalline silicon. The trick: they consist of several semi-conductor ...
Cached Biology News:New method for safer dosing of anticoagulants 2Winning early-career researchers excel in entrepreneurship 2Winning early-career researchers excel in entrepreneurship 3Fraunhofer researchers receive the Franco-German Business Award 2011 2
Rabbit polyclonal to LCAT ( Abpromise for all tested applications). entrezGeneID: 3931 SwissProtID: P04180...
Sheep polyclonal to Malate Dehydrogenase ( Abpromise for all tested applications). Antigen: Full length protein - Pig heart malate dehydrogenase. Entrez Gene ID: 4190 Swiss Protein ID: P...
Mouse monoclonal [7E10] to C Peptide ( Abpromise for all tested applications). entrezGeneID: 3630 SwissProtID: P01308...
...
Biology Products: